NASDAQ:NEO

Neogenomics Stock News

Healthcare > Medical - Diagnostics & Research

Buy NEO

*Your capital is at risk

$10.14

+0.0200 (+0.198%)

At Close: Jun 03, 2026

NeoGenomics Is On The Upswing, Reversing A CEO-Tied Sell-Off, On Bullish Long-Term Guidance

11:51am, Wednesday, 15'th Jan 2025

NeoGenomics stock jumped Wednesday after the company issued a strong 2025 outlook. That partially reversed a recent selloff.

NeoGenomics Provides 2025 Financial Guidance and Updates Long-Range Financial Plan

07:05am, Wednesday, 15'th Jan 2025

FT. MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics today provided financial guidance for fiscal year 2025 and updated its Long-Range Financial Plan.

NeoGenomics (NEO) Surges 9.1%: Is This an Indication of Further Gains?

05:56am, Wednesday, 15'th Jan 2025

NeoGenomics (NEO) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength

Adaptive Biotechnologies and NeoGenomics Partner to Expand Access to Personalized Disease Monitoring for Blood Cancer Patients

07:30am, Tuesday, 14'th Jan 2025

Pairing Adaptive Biotechnologies' clonoSEQ MRD results with NeoGenomics' COMPASS and CHART assessment services empowers clinicians and patients with meaningful insights across the treatment continuum

NeoGenomics Announces Chief Executive Officer Succession

07:05am, Friday, 10'th Jan 2025

FT. MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics' Chris Smith will retire as CEO and board member, effective April 1, 2025. Tony Zook will assume the role of CEO at that time.

NEO Battery Materials Unveils Breakthrough Silicon Battery Capacity, Expanding to Space Industry with Solid-State Batteries

09:30am, Tuesday, 07'th Jan 2025

TORONTO, Jan. 07, 2025 (GLOBE NEWSWIRE) -- NEO Battery Materials Ltd. (T S X V : NBM) (OTC: NBMFF), a low-cost silicon anode materials developer that enables longer-running, rapid-charging lithium-ion

NeoGenomics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

07:55am, Monday, 06'th Jan 2025

FT. MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics will attend the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco.

NeoGenomics (NEO) Upgraded to Buy: Here's Why

01:01pm, Monday, 30'th Dec 2024

NeoGenomics (NEO) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

NEO Battery Materials and Specialty Automotive Battery Cell Manufacturer Sign Joint Development Agreement for Silicon-Enhanced Battery Technology

09:30am, Thursday, 19'th Dec 2024

TORONTO, Dec. 19, 2024 (GLOBE NEWSWIRE) -- NEO Battery Materials Ltd. (T S X V : NBM) (OTC: NBMFF), a low-cost silicon anode materials developer that enables longer-running, rapid-charging lithium-ion

NeoGenomics' Newly Published Study Underscores Potential of ctDNA as a Predictive Tool for Monitoring Patients with High-Risk Melanoma

08:05am, Wednesday, 11'th Dec 2024

FT. MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics' newly published study shows how ctDNA in MRD may enable earlier identification of disease recurrence for high-risk melanoma patients.

NeoGenomics to Present Key Research on Hematologic Malignancies at the 2024 American Society of Hematology Annual Meeting

08:10am, Monday, 09'th Dec 2024

FT. MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics will present research on hematologic malignancies and the prognostic effects of microenvironment signatures in primary CNS lymphoma at ASH.

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by